COO: The Cooper Companies, Inc. Stock

SIC 3851 – Ophthalmic Goods

Valuation
Market Cap ($M) 17,896.02
Enterprise Value ($M) 20,533.32
Book Value ($M) 7,695.30
Book Value / Share 38.72
Price / Book 2.33
NCAV ($M) -2,543.40
NCAV / Share -12.80
Price / NCAV -7.04

Profitability (mra)
Return on Invested Capital (ROIC) 0.03
Return on Assets (ROA) 0.03
Return on Equity (ROE) 0.04

Liquidity (mrq)
Quick Ratio 1.08
Current Ratio 1.86

Balance Sheet (mrq) ($M)
Current Assets 1,793.90
Assets 12,032.60
Liabilities 4,337.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3,593.20
Operating Income 561.80
Net Income 294.20
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 607.50
Cash from Investing -449.00
Cash from Financing -173.90

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-16 13G/A T. Rowe Price Investment Management, Inc. 3.70 0.00
02-13 13G/A Vanguard Group Inc 11.57 2.67
01-25 13G/A BlackRock Inc. 8.80 14.43

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended January 31, 2024 ☐ Transition Report Pursuant t
2023-12-08 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED OCTOBER 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTIO
2023-08-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended July 31, 2023 ☐ Transition Report Pursuant to S
2023-06-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended April 30, 2023 ☐ Transition Report Pursuant to

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-23 96,736 673,761 14.36
2024-04-22 112,535 629,662 17.87
2024-04-19 135,074 502,163 26.90
2024-04-18 174,438 414,670 42.07

(click for more detail)

Similar Companies
EYE – National Vision Holdings, Inc.


Financial data and stock pages provided by
Fintel.io